Showing results (651-660 of 683) with videos related to

Sort By:
Pageof 69
Anticancer Research|July 3, 2017
A Novel mTOR Inhibitor; Anthracimycin for the Treatment of Human Hepatocellular CarcinomaTomoyuki Hayashi, Taro Yamashita, Hikari Okada, et al.
BMJ Open|July 6, 2026
VIR-SAAF: a study protocol for a national decentralised randomised controlled trial of home-based sleep apnoea screening in patients with atrial fibrillation in DenmarkMads Hashiba, Dominik Linz, Rune Frandsen, et al.
Antibiotics (Basel, Switzerland)|May 28, 2022
Exploration of Trends in Antimicrobial Use and Their Determinants Based on Dispensing Information Collected from Pharmacies throughout Japan: A First ReportYuichi Muraki, Masayuki Maeda, Ryo Inose, et al.
Cancer Science|August 25, 2017
Phase 1 study of veliparib with carboplatin and weekly paclitaxel in Japanese patients with newly diagnosed ovarian cancerShin Nishio, Munetaka Takekuma, Satoshi Takeuchi, et al.
Advances in Respiratory Medicine|April 27, 2026
Prognostic Impact of Serum Transthyretin and Sarcopenia on 3-Year Mortality and Respiratory-Related Hospitalizations in Idiopathic Pulmonary Fibrosis: A Prospective Cohort StudyAkihito Okada, Akiko Nakano, Kohei Fujita, et al.
Cancer Science|July 1, 2017
Phase 1 dose-escalation study of single-agent veliparib in Japanese patients with advanced solid tumorsTadaaki Nishikawa, Koji Matsumoto, Kenji Tamura, et al.
Nanotoxicology|September 28, 2011
Pulmonary toxicity of well-dispersed single-wall carbon nanotubes after inhalationYasuo Morimoto, Masami Hirohashi, Norihiro Kobayashi, et al.
Cellular and Molecular Gastroenterology and Hepatology|March 15, 2020
Inactivation of Transcriptional Repressor Capicua Confers Sorafenib Resistance in Human Hepatocellular CarcinomaTomomi Hashiba, Taro Yamashita, Hikari Okada, et al.
Circulation Reports|September 12, 2025
Priorities for Early Revascularization or Introduction of Mechanical Circulatory Support in Patients With Acute Coronary Syndrome Complicated by Cardiogenic Shock - A Systematic Review and Meta-AnalysisAya Katasako-Yabumoto, Kazuo Sakamoto, Katsutaka Hashiba, et al.
Gynecologic Oncology|December 21, 2021
Impact of veliparib, paclitaxel dosing regimen, and germline BRCA status on the primary treatment of serous ovarian cancer - an ancillary data analysis of the VELIA trialCarol Aghajanian, Elizabeth M Swisher, Aikou Okamoto, et al.
Pageof 69